Triton’s research report states that the cough syrup market in Asia-Pacific is estimated to advance with a CAGR of 4.01% in revenue during the forecast period 2023-2030. China, South Korea, Japan, India, Australia & New Zealand, ASEAN countries, and Rest of Asia-Pacific are evaluated in the region.
In recent years, India has witnessed a notable demographic shift, with approximately 10% of its populace falling into the geriatric category. This has emerged as a driving force behind the expansion of the cough syrup market within the country. The elderly, owing to their weakened immune systems and age-related health concerns, are more vulnerable to respiratory issues such as coughs and colds. Hence, a heightened need for efficient cough syrups has surged among this demographic, leading to the consistent growth of the cough syrup market in India as it endeavors to meet the rising healthcare requirements.
Respiratory illnesses like the common cold, flu, and cough-related disorders are seeing an upward trend in South Korea. Recent health data highlights a growing occurrence of these ailments, affecting a substantial portion of the population annually. Factors like air pollution, seasonal variations, and lifestyle choices collectively play a role in this surge in respiratory disorders, leading to a heightened demand for remedies like cough syrups.
Competitive Outlook
The well-known companies in the cough syrup market include GSK Plc, Novartis AG, The Procter & Gamble Company, Sanofi SA, Pfizer Inc, and Cipla Limited.
1. Asia-pacific Cough Syrup Market - Summary
2. Industry Outlook
2.1. Impact Analysis On The Cough Syrup Market
2.1.1. Covid-19 Impact
2.1.2. Ukraine-russia War Impact
2.2. Porter’s Five Forces Analysis
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitutes
2.2.3. Bargaining Power Of Buyers
2.2.4. Bargaining Power Of Suppliers
2.2.5. Threat Of Competitive Rivalry
2.3. Industry Components
2.3.1. Raw Materials
2.3.2. Manufacturers
2.3.3. Distributors
2.3.4. Retailers
2.4. Regulatory Framework
2.5. Key Market Strategies
2.5.1. Collaborations
2.5.2. Product Launches
2.5.3. Acquisitions
2.5.4. Business Divestitures & Expansions
2.6. Market Drivers
2.6.1. High Incidence Of Respiratory Ailments
2.6.2. Vulnerability To Respiratory Diseases Among The Geriatric Population
2.6.3. Innovations In Cough Syrups
2.7. Market Challenges
2.7.1. Overdose Risks Associated With Cough Syrups
2.7.2. Strict Regulatory Requirements
2.7.3. Increasing Cough Syrup Deaths Due To Toxic Ingredients
2.8. Market Opportunities
2.8.1. Self-medication Trends Increase Demand For Otc Drugs
2.8.2. Herbal Cough Syrups Emerge As A Safer Alternative
2.8.3. Ease Of Purchase Offered By E-commerce Channels
2.8.4. Availability Of Sugar-free Cough Syrups
2.8.5. Growing Preference For Homeopathic Cough Syrups
2.9. Analyst Perspective
3. Asia-pacific Cough Syrup Market – By Product Type
3.1. Cough Suppressants
3.2. Combination Medicines
3.3. Expectorants
4. Asia-pacific Cough Syrup Market – By Age Group
4.1. Adults
4.2. Adolescents
4.3. Pediatric
5. Asia-pacific Cough Syrup Market – By Distribution Channel
5.1. Retail Pharmacies
5.2. Hospital Pharmacies
5.3. E-pharmacies
6. Asia-pacific Cough Syrup Market – By Country Outlook
6.1. China
6.1.1. China Cough Syrup Market Forecast & Prospects
6.2. Japan
6.2.1. Japan Cough Syrup Market Forecast & Prospects
6.3. India
6.3.1. India Cough Syrup Market Forecast & Prospects
6.4. South Korea
6.4.1. South Korea Cough Syrup Market Forecast & Prospects
6.5. Asean Countries
6.5.1. Asean Countries Cough Syrup Market Forecast & Prospects
6.6. Australia & New Zealand
6.6.1. Australia & New Zealand Cough Syrup Market Forecast & Prospects
6.7. Rest Of Asia-pacific
6.7.1. Rest Of Asia-pacific Cough Syrup Market Forecast & Prospects
7. Competitive Landscape
7.1. Gsk Plc
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Strengths
7.1.4. Key Challenges
7.2. Pfizer Inc
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Strengths
7.2.4. Key Challenges
7.3. Novartis Ag
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Strengths
7.3.4. Key Challenges
7.4. Reckitt Benckiser Group Plc
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Strengths
7.4.4. Key Challenges
7.5. The Procter & Gamble Company
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Strengths
7.5.4. Key Challenges
7.6. Sanofi Sa
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Strengths
7.6.4. Key Challenges
7.7. Cipla Limited
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Strengths
7.7.4. Key Challenges
7.8. Kenvue Inc
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Strengths
7.8.4. Key Challenges
7.9. Astrazeneca Plc
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Strengths
7.9.4. Key Challenges
7.10. Acella Pharmaceuticals Llc
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Strengths
7.10.4. Key Challenges
7.11. The Himalaya Wellness Company
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Strengths
7.11.4. Key Challenges
7.12. Merck Kgaa
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Strengths
7.12.4. Key Challenges
7.13. Abbott Laboratories
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Strengths
7.13.4. Key Challenges
7.14. Glenmark Pharmaceuticals Limited
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Strengths
7.14.4. Key Challenges
7.15. Dabur India Ltd
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Strengths
7.15.4. Key Challenges
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.2. Sources Of Data
8.3. Research Methodology
List Of Tables
Table 1: Asia-pacific Cough Syrup Market, By Country Outlook, 2023-2030 (In $ Million)
Table 2: Regulatory Framework
Table 3: List Of Collaborations
Table 4: List Of Product Launches
Table 5: List Of Acquisitions
Table 6: List Of Business Divestitures & Expansions
Table 7: Asia-pacific Cough Syrup Market, By Product Type, 2023-2030 (In $ Million)
Table 8: Asia-pacific Cough Syrup Market, By Age Group, 2023-2030 (In $ Million)
Table 9: Asia-pacific Cough Syrup Market, By Distribution Channel, 2023-2030 (In $ Million)
Table 10: Asia-pacific Cough Syrup Market, By Country Outlook, 2023-2030 (In $ Million)
List Of Figures
Figure 1: Industry Components
Figure 2: Asia-pacific Cough Syrup Market, By Product Type, 2022 & 2030 (In %)
Figure 3: Asia-pacific Cough Syrup Market, By Cough Suppressants, 2023-2030 (In $ Million)
Figure 4: Asia-pacific Cough Syrup Market, By Combination Medicines, 2023-2030 (In $ Million)
Figure 5: Asia-pacific Cough Syrup Market, By Age Group, 2022 & 2030 (In %)
Figure 6: Asia-pacific Cough Syrup Market, By Adults, 2023-2030 (In $ Million)
Figure 7: Asia-pacific Cough Syrup Market, By Adolescents, 2023-2030 (In $ Million)
Figure 8: Asia-pacific Cough Syrup Market, By Pediatric, 2023-2030 (In $ Million)
Figure 9: Asia-pacific Cough Syrup Market, By Distribution Channel, 2022 & 2030 (In %)
Figure 10: Asia-pacific Cough Syrup Market, By Retail Pharmacies, 2023-2030 (In $ Million)
Figure 11: Asia-pacific Cough Syrup Market, By Hospital Pharmacies, 2023-2030 (In $ Million)
Figure 12: Asia-pacific Cough Syrup Market, By E-pharmacies, 2023-2030 (In $ Million)
Figure 13: Asia-pacific Cough Syrup Market, By Country Outlook, 2022 & 2030 (In %)
Figure 14: China Cough Syrup Market 2023-2030 (In $ Million)
Figure 15: Japan Cough Syrup Market 2023-2030 (In $ Million)
Figure 16: India Cough Syrup Market 2023-2030 (In $ Million)
Figure 17: South Korea Cough Syrup Market 2023-2030 (In $ Million)
Figure 18: Asean Countries Cough Syrup Market 2023-2030 (In $ Million)
Figure 19: Australia & New Zealand Cough Syrup Market 2023-2030 (In $ Million)
Figure 20: Rest Of Asia-pacific Cough Syrup Market 2023-2030 (In $ Million)